Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X
Scientific presentation

Clonal evolution underlying clinical responses and relapses in subjects with IDH1-mutated AML treated with ivosidenib monotherapy or ivosidenib + azacitidine


Dylan Marchione, PhD
Description

At this year’s World CB & CDx conference held in Boston, Dylan Marchione, PhD, of Servier Pharmaceuticals presented data supporting the use of the Tapestri Platform in clinical development to elucidate clonal evolution patterns in patients with IDH1-mutated AML treated with combination therapy, TIBSOVO + azacitidine, as compared to monotherapy.



VIEW


Scientific presentation
Single-cell Multi-omics for Discovery, Translational, and Clinical Development
Gema Fuerte, PhD
World CDx Europe (2024)
Scientific presentation
Confidently Validate Cancer Models for Precision Medicine
Dr. Robert Bowman
Divya Rao
(2024)
Scientific presentation
Unveiling Cellular Complexity: Why & How to Integrate Single-Cell DNA Multi-omics
Brittany Enzmann, PhD
Divya Rao, PhD
Adam Sciambi, PhD
(2024)
Scientific presentation
Unleashing the Potential of CRISPR & Navigating Heterogeneity in Genome Editing Outcomes
Travis Hardcastle, Synthego
Brittany Enzmann, Mission Bio
(2024)
REQUEST QUOTE